Joshua Silverman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joshua Silverman
Joshua Silverman is recorded as CEO at PharmaCyte Biotech, Inc. (PMCB). PharmaCyte Biotech, Inc. reported in an 8-K filed November 18, 2022 that Joshua Silverman was appointed Interim President, effective November 14, 2022. PharmaCyte Biotech, Inc. reported in an 8-K filed November 18, 2022 that Joshua Silverman was appointed Interim Chief Executive Officer, effective November 14, 2022.
“On November 14, 2022, the Board formally approved the employment of Joshua Silverman as Interim Chief Executive Officer and Interim President of the Company on a month-to-month basis, and it further approved paying Mr. Silverman a monthly salary of $31,250.”
“On November 14, 2022, the Board formally approved the employment of Joshua Silverman as Interim Chief Executive Officer and Interim President of the Company on a month-to-month basis, and it further approved paying Mr. Silverman a monthly salary of $31,250.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-11-14–present
-
PharmaCyte Biotech, Inc. (PMCB)
SEC 8-K
Current2022-11-14–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at PharmaCyte Biotech, Inc.
Other people whose current roles at this company are on record from its filings.
- Joshua N. Silverman CEO, Chairman, Board Member
- Gerald W. Crabtree CTO
- Daniel Allen Board Member
- Jack E. Stover Board Member
- Jonathan L. Schechter Board Member
- Michael M. Abecassis Board Member
- Robert Weinstein Board Member
- Wayne R. Walker Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.